Log in to save to my catalogue

Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease

Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9e01bc89a95e413fbdff0e9ee7e5a51b

Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease

About this item

Full title

Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2021-03, Vol.12 (1), p.1592-1592, Article 1592

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Parkinson’s disease (PD) is a progressive neurodegenerative disorder, which is characterised by degeneration of distinct neuronal populations, including dopaminergic neurons of the substantia nigra. Here, we use a metabolomics profiling approach to identify changes to lipids in PD observed in sebum, a non-invasively available biofluid. We used liqu...

Alternative Titles

Full title

Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9e01bc89a95e413fbdff0e9ee7e5a51b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9e01bc89a95e413fbdff0e9ee7e5a51b

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-021-21669-4

How to access this item